Giselle Sholler Advances in Neuroblastoma Research Congress 2016

Abstracts this author is presenting:

• DFMO maintains remission and increases overall survival in high risk neuroblastoma: results of a phase II prevention trial — Parallel 10 High Risk Neuroblastoma